GenPath provides expertise in cancer diagnostics and offers a complete portfolio to provide a single source solution laboratory for cancer patients' needs.
Webinar alert on 2/21! Archer, of Integrated DNA Technologies, & speaker Wojciech Swat, PhD, FACMG, Medical Director at GenPath® Oncology will speak on advanced comprehensive genomic panels for myeloid neoplasms. ➡️ https://t.co/l9MSlWwTQJ
Attending the 64th #ASH Meeting? Our team would love to connect! Meet us at booth #305 and let’s discuss how GenPath's comprehensive test offerings can support the continuum of care of your patients with #blood disorders.
Are you attending the 64th #ASH Meeting in New Orleans? Connect with our team at booth #305 to discover our cutting edge #NGS portfolio for hematologic malignancies with unmatched turnaround times for results.
Are you planning to attend #AMP2022 in Phoenix, Arizona? Come see us at booth 732 to learn about our cutting edge #NGS panels and new test offerings for chronic lymphocytic leukemia (CLL).
Today is #WorldLungCancerDay – an opportunity to raise awareness about this disease and highlight the risk factors, screening, and treatment options. Learn more about #lungcancer here: https://t.co/d25aktLypN
#UVSafetyMonth brings a time to shine a light on the importance of sun safety and #skincancer prevention. Read about risk factors for skin cancer – like exposure to UV light – sun protection, and more, here: https://t.co/jW1yU3mkhh
Overexposure to the sun can cause irreversible #skin damage such as dark spots and wrinkles, and may also increase the chance of developing #skincancer https://t.co/43z9qRB05Q. #uvsafetyawarenessmonth#uvsafety
Participating in outdoor activities is one of the best parts of summer. While enjoying the warm weather, be sure to protect your skin from the sun by applying sunscreen, wearing protective clothes and hats, sunglasses, etc. Learn more here https://t.co/w6GQ1UMIeF #uvsafetymonth
GenPath® Oncology, a specialty division of BioReference Laboratories will be exhibiting at the 2022 #ASCO Annual Meeting. Visit booth 3138 to learn about GenPath’s state-of-the-art #NGS and other testings.
We are delighted to attend the 2022 American Society of Clinical Oncology #ASCO Annual Meeting. Please meet us at booth 3138. We hope to see you there!
GenPath® Oncology, a specialty division of BioReference Laboratories will be exhibiting at the 2022 #ASCO Annual Meeting. Visit booth 3138 to learn about GenPath’s state-of-the-art #NGS and other testings.
We are delighted to attend the 2022 American Society of Clinical Oncology #ASCO Annual Meeting. Please meet us at booth 3138. We hope to see you there!
GenPath® Oncology, a specialty division of BioReference Laboratories will be exhibiting at the 2022 #ASCO Annual Meeting. Visit booth 3138 to learn about GenPath’s state-of-the-art #NGS and other testings.
Smoking causes about 20% of all cancers and about 30% of all cancer deaths in the U.S. https://t.co/sQdtcZ7blf. This World No-Tobacco Day, join us in sharing crucial health information about the dangers of smoking and tobacco use https://t.co/diArpsMn1Q #WorldNoTobaccoDay
We are delighted to attend the 2022 American Society of Clinical Oncology #ASCO Annual Meeting. Please meet us at booth 3138. We hope to see you there!
A mole that is changing in size, shape, or color, is one of the warning signs of skin cancer. https://t.co/A8mElo3SlZ Regular self-examination of your skin may help identify early signs of skin cancer. Learn how to do a skin self-exam here https://t.co/blwXE1OGu2
Melanoma is a #skincancer type that develops when melanocytes (the cells that give the skin its tan or brown color) grow out of control. It accounts for 1% of skin cancer but is more dangerous and likely to spread to other body parts. https://t.co/Rs2NSZsguC.
Melanoma and other skin cancers can be prevented by avoiding too much exposure to Ultraviolet (UV) rays and protecting your skin from the sun through the use of sunscreens, hats, and sunglasses. Can melanoma be found early? Find out here https://t.co/raFezdNqCU #MelanomaMonday
GeneDx, Inc. has been acquired by Sema4, allowing BioReference to focus efforts on realizing our goals and continue investments into digitally-enabled, innovative and customized healthcare solutions. Read more here https://t.co/faDj0g819c